![Sujal Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sujal Shah
Plus aucun poste en cours
Fortune : - $ au 31/07/2026
Profil
Sujal Shah currently works at Tvardi Therapeutics, Inc., as Chairman from 2025.
Mr. Shah also formerly worked at CymaBay Therapeutics, Inc., as President, Chief Executive Officer & Director from 2017 to 2024, Tvardi Therapeutics, Inc. (Old), as Chairman from 2024 to 2025, Citigroup, Inc., as Director-Health Care Investment Banking from 2010 to 2012, Opthea Ltd., as Independent Non-Executive Director from 2024 to 2025, and Credit Suisse Global Opportunities Advisors LLC, as Vice President-Healthcare Investment Banking Group from 2004 to 2010.
Mr. Shah received his undergraduate degree and graduate degree from Northwestern University and Masters Business Admin degree from Tepper School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/09/2025 | 0 ( -.--% ) | - $ | 31/07/2026 | |
-.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Sujal Shah
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Sujal Shah
| Sociétés | Poste | Fin |
|---|---|---|
| CERYVYN THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 15/09/2025 |
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Président | 15/04/2025 |
| CYMABAY THERAPEUTICS, INC. | Directeur Général | 22/03/2024 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/01/2012 |
Credit Suisse Global Opportunities Advisors LLC
 Credit Suisse Global Opportunities Advisors LLC Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01/01/2010 |
Formation de Sujal Shah
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Citigroup, Inc.
 Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Credit Suisse Global Opportunities Advisors LLC
Credit Suisse Global Opportunities Advisors LLC Investment ManagersFinance Provides investment advice | Finance |
Tepper School of Business
 Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
